Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3771068010 | Fenoterol and ipratropium only product in pulmonary dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3771069019 | Product containing only fenoterol and ipratropium in pulmonary dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4661361000052113 | läkemedel som endast innehåller fenoterol och ipratropium, pulmonell läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Fenoterol and ipratropium only product in pulmonary dose form | räkning av bas i aktiv ingrediens | två | false | Inferred relationship | Some | ||
Fenoterol and ipratropium only product in pulmonary dose form | Is a | Product containing fenoterol and ipratropium in pulmonary dose form (medicinal product form) | true | Inferred relationship | Some | ||
Fenoterol and ipratropium only product in pulmonary dose form | Has manufactured dose form | Pulmonary dose form (dose form) | true | Inferred relationship | Some | ||
Fenoterol and ipratropium only product in pulmonary dose form | Is a | Fenoterol and ipratropium only product | true | Inferred relationship | Some | ||
Fenoterol and ipratropium only product in pulmonary dose form | Has active ingredient | Fenoterol (substance) | true | Inferred relationship | Some | 2 | |
Fenoterol and ipratropium only product in pulmonary dose form | Has active ingredient | Ipratropium (substance) | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) | Is a | True | Fenoterol and ipratropium only product in pulmonary dose form | Inferred relationship | Some |
This concept is not in any reference sets